pGEX-2TK-WW-CR-W3083F
(Plasmid
#18076)
-
Depositing Lab
-
Publication
-
Sequence Information
Full plasmid sequence is not available for this item.
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 18076 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepGEX-2TK (Pharmacia)
-
Backbone manufacturerPhramacia
- Backbone size w/o insert (bp) 4969
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameDystrophin
-
SpeciesH. sapiens (human)
-
Insert Size (bp)900
-
MutationSecond conserved Tryptophan (W) of the WW domain at amino acid position 3083 was changed to Phenylalanine (F)
-
GenBank IDNM_004006
-
Entrez GeneDMD (a.k.a. BMD, CMD3B, DXS142, DXS164, DXS206, DXS230, DXS239, DXS268, DXS269, DXS270, DXS272, MRX85)
-
Tag
/ Fusion Protein
- GST (N terminal on backbone)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BamHI (unknown if destroyed)
- 3′ cloning site EcoRI (unknown if destroyed)
- 5′ sequencing primer N/A (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byWe obtained the partial cDNA for human dystrophin from ATCC. That cDNA served as a template for generation of constructs we produced in pGEX2TK
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pGEX-2TK-WW-CR-W3083F was a gift from Marius Sudol (Addgene plasmid # 18076 ; http://n2t.net/addgene:18076 ; RRID:Addgene_18076) -
For your References section:
The WW domain of dystrophin requires EF-hands region to interact with beta-dystroglycan. Rentschler S, Linn H, Deininger K, Bedford MT, Espanel X, Sudol M. Biol Chem. 1999 Apr . 380(4):431-42. 10.1515/BC.1999.057 PubMed 10355629
Map uploaded by the depositor.